<DOC>
	<DOCNO>NCT02695381</DOCNO>
	<brief_summary>This study evaluate efficacy safety Etodolac-lidocaine topical patch apply one time daily compare placebo treatment acute Delayed Onset Muscle Soreness ( DOMS ) upper limb .</brief_summary>
	<brief_title>Etodolac-lidocaine Patch Subjects Experiencing Acute Delayed Onset Muscle Soreness</brief_title>
	<detailed_description />
	<mesh_term>Myalgia</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Etodolac</mesh_term>
	<criteria>Have engage significant upper extremity fitness activity two time per week â‰¥ 2 consecutive week past 6 month prior screen . Subject body mass index 18 30 kg/m2 , inclusive . Subjects report pain movement score arm least 5 ( base 010 NRS ) secondary DOMS approximately 24 30 hour arm exercise . Presence another painful physical condition , opinion Investigator , may confound study assessment . Use pain medication ( include antiinflammatory drug ) prior Exercise Visit 72 hour randomization . Use corticosteroid ( oral , injectable , topical , inhale ) Exercise Visit randomization . Corticosteroids must wash least 3 day Exercise Visit . Chronic acute renal hepatic disorder , inflammatory bowel disease ( e.g. , Crohn 's disease ulcerative colitis ) significant coagulation defect . History allergy ( cutaneous systemic ) , asthma , hypersensitivity following : etodolac , lidocaine , paracetamol ( acetaminophen ) , acetylsalicylic acid , salicylic acid , NSAID , local anesthetic , know intolerance ( cutaneous systemic ) ingredient patch .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>